BAALC expression predicts clinical outcome of de novo acute myeloid leukemia patients with normal cytogenetics: a Cancer and Leukemia Group B Study.
Baldus, Claudia D
BAALC expression predicts clinical outcome of de novo acute myeloid leukemia patients with normal cytogenetics: a Cancer and Leukemia Group B Study. [electronic resource] - Blood Sep 2003 - 1613-8 p. digital
Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
0006-4971
10.1182/blood-2003-02-0359 doi
Acute Disease
Adult
Antineoplastic Combined Chemotherapy Protocols--administration & dosage
Cytarabine--administration & dosage
Daunorubicin--administration & dosage
Etoposide--administration & dosage
Female
Genetic Markers
Genetic Predisposition to Disease--epidemiology
Humans
Karyotyping
Leukemia, Myeloid--epidemiology
Male
Middle Aged
Multivariate Analysis
Neoplasm Proteins--genetics
Predictive Value of Tests
Prognosis
Reverse Transcriptase Polymerase Chain Reaction
Risk Factors
Treatment Outcome
BAALC expression predicts clinical outcome of de novo acute myeloid leukemia patients with normal cytogenetics: a Cancer and Leukemia Group B Study. [electronic resource] - Blood Sep 2003 - 1613-8 p. digital
Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
0006-4971
10.1182/blood-2003-02-0359 doi
Acute Disease
Adult
Antineoplastic Combined Chemotherapy Protocols--administration & dosage
Cytarabine--administration & dosage
Daunorubicin--administration & dosage
Etoposide--administration & dosage
Female
Genetic Markers
Genetic Predisposition to Disease--epidemiology
Humans
Karyotyping
Leukemia, Myeloid--epidemiology
Male
Middle Aged
Multivariate Analysis
Neoplasm Proteins--genetics
Predictive Value of Tests
Prognosis
Reverse Transcriptase Polymerase Chain Reaction
Risk Factors
Treatment Outcome